carbapenems has been researched along with quinazolines in 1 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (quinazolines) | Trials (quinazolines) | Recent Studies (post-2010) (quinazolines) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 19,235 | 2,417 | 8,835 |
| Protein | Taxonomy | carbapenems (IC50) | quinazolines (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.027 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Merz, KM; Park, H | 1 |
1 other study(ies) available for carbapenems and quinazolines
| Article | Year |
|---|---|
Force field design and molecular dynamics simulations of the carbapenem- and cephamycin-resistant dinuclear zinc metallo-beta-lactamase from Bacteroides fragilis and its complex with a biphenyl tetrazole inhibitor.
Topics: Anti-Bacterial Agents; Apoenzymes; Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; Binding Sites; Carbapenems; Cephamycins; Crystallography, X-Ray; Drug Design; Drug Resistance, Multiple, Bacterial; Models, Molecular; Protein Binding; Quantitative Structure-Activity Relationship; Quinazolines; Tetrazoles; Zinc | 2005 |